Naratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches. It is grouped under the following drug class(es): Serotonin agents and Triptans. Its therapeutic use is listed as analgesics and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Naramig, N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide 1H-Indole-5-ethanesulfonamide and N-methyl-3-(1-methyl-4-piperidinyl)- naratriptanum. Its PubChem CID is 4440.
Naratriptan
| CAS No | 121679-13-8 |
|---|---|
| Molecular Formula | C17H25N3O2S |
| Molecular Weight | 335.5 g/mol |
| Synonyms | N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Naratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches. It is grouped under the following drug class(es): Serotonin agents and Triptans.
The listed CAS number is 121679-13-8.
The listed molecular formula is C17H25N3O2S.
The listed molecular weight is 335.5 g/mol.
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide.
The source lists Naramig, N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide 1H-Indole-5-ethanesulfonamide and N-methyl-3-(1-methyl-4-piperidinyl)- naratriptanum.